Targeted mass spectrometry tests to measure cancer-related proteins
A proteomics research specialist in developing targeted mass spectrometry methods for quantifying proteins important in cancer
This program builds precise lab tests that measure proteins tied to cancer to help improve diagnosis and treatment choices for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11168721 on NIH RePORTER |
What this research studies
Our lab is creating and refining targeted mass spectrometry methods that can measure many cancer-related proteins and their chemical changes very precisely. We are also making standardized procedures and shared resources so other labs can run the same reliable tests. The team applies these methods to patient-derived samples to learn about cancer biology and to move useful tests toward clinical use. By spreading the methods to the wider research community, the goal is faster, more consistent protein testing across hospitals and studies.
Who could benefit from this research
Good fit: Patients with cancer who are willing to provide tumor tissue or blood samples for protein measurement, especially those interested in personalized treatment approaches, would be most relevant to this work.
Not a fit: People without cancer or patients expecting an immediate new therapy will likely not see direct treatment benefit from this methods-focused project.
Why it matters
Potential benefit: If successful, these standardized protein tests could make cancer diagnoses more accurate and help match patients to the best therapies.
How similar studies have performed: Targeted mass spectrometry has shown promising results in research and early clinical assays, but broader standardization and widespread clinical adoption are still in progress.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Whiteaker, Jeff — Fred Hutchinson Cancer Center
- Study coordinator: Whiteaker, Jeff
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.